Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"WHO International Clinical Trials Registry Platform"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&type=AllFields&page=3
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&type=AllFields&page=3
Search /vufind/Search2/Results?filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&type=AllFields&page=3
PubPharm (853.704)
21
A study to evaluate the effect of changing HIV medication (from a protease inhibitor or efavirenz to raltegravir) on liver fat, fat tissue and metabolic parameters (blood sugar and cholesterol, etc) in overweight or obese patients with metabolic problems. : A randomized, open, parallel design study to evaluate the effect on liver fat, adipose tissue and metabolic parameters when switching a protease inhibitor or efavirenz to once daily raltegravir in HIV-infected patients with body mass index over 25 kg/m2 and with at least one metabolic syndrome component. - OBERAL
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
22
A Phase 4 clinical trial to measure the effect of Obeticholic acid against a placebo, in conjunction with standard treatment, on selected clinical measurements in patients with the liver disease, Primary Biliary Cholangitis.The COBALT Study Clinical Outcomes with OBeticholic Acid in Liver Treatment (COBALT). : A Phase 4, Double Blind, Randomized, Placebo Controlled, Multicenter Study Evaluating the Effect of Obeticholic Acid on Clinical Outcomes in Subjects with Primary Biliary Cholangitis. The COBALT Study Clinical Outcomes with OBeticholic Acid in Liver Treatment (COBALT).
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
23
A phase 3 trial studying how well E7080 works in treating patients with advanced thyroid cancer who no longer gain benefit from radioactive iodine therapy. The trial is taking place worldwide, patients and their physician do not know if they are receiving the active drug or a dummy drug. : A Multicenter, Randomized, Double-Blind, Placebo-Controlled,Phase 3 Trial of Lenvatinib E7080 in 131I-Refractory Differentiated Thyroid Cancer
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
24
A Phase III, Randomized, Double-blind Trial Comparing Trastuzumab Plus Chemotherapy and Pembrolizumab With Trastuzumab Plus Chemotherapy and Placebo as First-line Treatment in Participants With HER2 Positive Advanced Gastric or Gastroesophageal Junction Adenocarcinoma (KEYNOTE 811) : A Phase III, Randomized, Double-blind Trial Comparing Trastuzumab Plus Chemotherapy and Pembrolizumab With Trastuzumab Plus Chemotherapy and Placebo as First-line Treatment in Participants With HER2 Positive Advanced Gastric or Gastroesophageal Junction Adenocarcinoma (KEYNOTE 811)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
25
A multicenter clinical study with Nivolumab for subjects with confirmed stage III or stage IV melanoma after treament with an Anti-CTLA-4 antibody. : A Single-Arm, Open-Label, Multicenter Clinical Trial with Nivolumab (BMS-936558) for Subjects with Histologically Confirmed Stage III (unresectable) or Stage IV Melanoma Progressing After Prior Treatment Containing an Anti-CTLA-4 Monoclonal Antibody
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
26
Efficacy and safety of trimetazidine in patients with angina having been treated by dilatation of coronary arteries. : The efficAcy and safety of Trimetazidine in Patients withangina pectoris having been treated by percutaneous CoronaryIntervention. ATPCI studyAn international, multicentre, randomised, double-blind, placebo-controlled study in patients treated for 2 to 4 years.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
27
Study of Rituximab and Ibrutinib (RI) versus Dexamethasone, Rituximab and Cyclophosphamide (DRC) as initial therapy for Waldenström's macroglobulinaemia : Randomised phase II/III study of Rituximab and Ibrutinib (RI) versus Dexamethasone, Rituximab and Cyclophosphamide (DRC) as initial therapy for Waldenström's macroglobulinaemia - RAINBOW
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
28
A trial to evaluate the safety of long term treatment withnintedanib in patients with scleroderma related lung fibrosis. : An open-label extension trial to assess the long term safety ofnintedanib in patients with ‘Systemic Sclerosis associatedInterstitial Lung Disease’ (SSc-ILD) - SENSCIS(R) -ON
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
29
A review of the LightPath Imaging System using the tracer 68Ga-RM2 in helping to show the boundaries of the breast cancer during removal of the tumour. : Evaluation of the LightPath Imaging System and the PET tracer 68Ga-RM2 in wide local excision (WLE) for breast cancer
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
30
A modular multi-Basket trial to improve personalized medicine in cancer patients : Basket of Baskets: A Modular, Open-label, Phase II, Multicentre Study To Evaluate Targeted Agents in Molecularly Selected Populations With Advanced Solid Tumors. - VHIO17002 (UK)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
[1]
« Vorheriger
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[85371]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Zeitschrift: WHO International Clinical Trials Registry Platform
Medienart
853.704
Aufsätze
853.704
E-Artikel
853.704
E-Ressourcen
Zeitschriftentitel
WHO International Clinical Trials Registry Plat...
Thema
850.882
610
695.104
Study Type: Interventional
320.034
Recruitment Status: Not yet recruiting
182.938
Recruitment Status: Recruiting
182.310
Recruitment Status: Completed
125.472
Study Type: Observational
94.882
Phase: Phase 3
72.114
Phase: Phase 2
63.690
Recruitment Status: Complete: follow-up complete
60.420
Recruitment Status: Authorised-recruitment may ...
33.564
Phase: Phase 4
23.376
Phase: Phase 1
16.354
Phase: Phase 2/Phase 3
15.340
Phase: Other
12.074
Recruitment Status: Complete: follow-up continuing
9.066
Phase: New Treatment Measure Clinical Study
8.800
Phase: Phase 1/Phase 2
7.862
Phase: Retrospective study
7.002
Study Type: Diagnostic test
5.682
Study Type: Observational non invasive
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
572.390
2020-
281.314
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
832.720
Englisch
12.786
Unbestimmt
3.114
Spanisch
1.596
Niederländisch
1.504
Französisch
556
Deutsch
308
Dänisch
300
Finnisch
156
Italienisch
110
Schwedisch
56
Sanskrit
52
Galizisch
52
Portugiesisch
42
Latein
32
Norwegisch
30
Tschechisch
26
Afrikaans
26
Ungarisch
26
Slowakisch
18
Irisch
Alle anzeigen ...
weniger ...
Haven't found what you're looking for?
Wird geladen...